Emeryville, CA


Kyverna went public in February 2024 at a price of $22/share.

Aligns with calendar year.

Kyverna is traded on the Nasdaq Global Select Market.


Contact transfer agent.

Contact transfer agent.

None envisioned at this time.


Paul Hastings LLP

78 as of September 30, 2023.

To find out more about us visit our webpage at www.kyvernatx.com.

Our press release archive can be viewed under the “Press Releases” section and our financial reports are available under the “Financial Information” section, both under the “Investors” link on our website www.kyvernatx.com.

Our SEC Filings can be found on www.sec.gov and are also available under the “Financial Information” section under the “Investors” link on our website https://www.kyvernatx.com.

For a list of our Executive Management team and Board of Directors please visit the “Inside Kyverna” tab of our website.

Please access our website at www.kyvernatx.com.

All of our upcoming events are available in the calendar section of the investor relations webpage. You are also able to sign up for email updates from Kyverna which will inform you of the latest events, or reports regarding Kyverna. The signup link is available at the investor relations webpage as well.

For investor inquiries please contact:
George Thampy
Kyverna Therapeutics
E-mail: gthampy@kyvernatx.com

Brian Cheng, JPMorgan
Mike Ulz, MorganStanley
Tom Smith, Leerink
Derek Archila, Wells Fargo

You can find the latest annual report and proxy statement on our Financials and Filings page or directly from the SEC at www.sec.gov.

The date and location of the next annual meeting will be communicated prior to the meeting date.